BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2989306)

  • 1. Assay of human erythrocyte pyrimidine and deoxypyrimidine 5'-nucleotidase by isocratic reversed-phase high-performance liquid chromatography.
    Cook L; Schafer-Mitchell M; Angle C; Stohs S
    J Chromatogr; 1985 May; 339(2):293-301. PubMed ID: 2989306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics.
    Cook L; Kubitschek C; Stohs S; Angle C
    Drug Chem Toxicol; 1988 Jun; 11(2):195-213. PubMed ID: 2841083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some properties of human erythrocyte pyrimidine 5'-nucleotidase.
    Torrance JD; Whittaker DA
    Enzyme; 1981; 26(2):64-73. PubMed ID: 6263612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isozymes of human erythrocyte pyrimidine 5'-nucleotidase.
    Oda T; Nagao M; Shirono K; Kagimoto T; Takatsuki K
    J Lab Clin Med; 1985 Dec; 106(6):646-50. PubMed ID: 2999273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of human erythrocyte 5'-nucleotidases in healthy individuals and a patient deficient in pyrimidine 5'-nucleotidase.
    Swallow DM; Aziz I; Hopkinson DA; Miwa S
    Ann Hum Genet; 1983 Jan; 47(1):19-23. PubMed ID: 6301356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of a pyrimidine-specific 5'-nucleotidase in human erythrocytes.
    Paglia DE; Valentine WN
    J Biol Chem; 1975 Oct; 250(20):7973-9. PubMed ID: 240846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isozymes of human erythrocyte pyrimidine 5'-nucleotidase--chromatographic separation and their properties.
    Hirono A; Fujii H; Miwa S
    Jpn J Exp Med; 1985 Feb; 55(1):37-44. PubMed ID: 2993713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.
    Cook LR; Angle CR; Stohs SJ
    Br J Ind Med; 1986 Jun; 43(6):387-90. PubMed ID: 3013277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and properties of human erythrocyte pyrimidine 5'-nucleotidase.
    Torrance JD; Whittaker D; Beutler E
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3701-4. PubMed ID: 20631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrimidine nucleotidase deficiency with active dephosphorylation of dTMP: evidence for existence of thymidine nucleotidase in human erythrocytes.
    Paglia DE; Valentine WN; Keitt AS; Brockway RA; Nakatani M
    Blood; 1983 Nov; 62(5):1147-9. PubMed ID: 6313098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity and pH sensitivity of deoxyribonucleotidase and pyrimidine nucleotidase activities in human hemolysates.
    Paglia DE; Valentine WN; Brockway RA; Nakatani M
    Exp Hematol; 1987 Nov; 15(10):1041-7. PubMed ID: 2822457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A continuous spectrophotometric assay for pyrimidine-5'-nucleotidase.
    Zerez CR; Tanaka KR
    Anal Biochem; 1985 Dec; 151(2):282-5. PubMed ID: 3006535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radioassay for pyrimidine-5'-nucleotidase activity.
    Buc H; Kaplan JC
    Clin Chim Acta; 1978 Apr; 85(2):193-6. PubMed ID: 647979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple determination of erythrocyte pyrimidine 5'-nucleotidase activity in human blood by high-performance liquid chromatography.
    Tomokuni K; Ichiba M
    Ind Health; 1986; 24(4):227-33. PubMed ID: 3028992
    [No Abstract]   [Full Text] [Related]  

  • 16. HPLC analysis of erythrocyte pyrimidine-5'-nucleotidase inhibition by lead.
    Rocco RM; Smart JL; Brown DR; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):127-36. PubMed ID: 6273981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of 5'-nucleotidase activity in human erythrocytes and plasma using high-performance liquid chromatography.
    Sakai T; Yanagihara S; Ushio K
    J Chromatogr; 1982 Apr; 239():717-21. PubMed ID: 6284776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrimidine metabolism in hereditary erythrocyte pyrimidine 5' nucleotidase deficiency.
    Harley EH; Heaton A; Wicomb W
    Metabolism; 1978 Dec; 27(12):1743-54. PubMed ID: 723629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell pyrimidine 5' nucleotidase deficiency: determination of nucleotidase activity and nucleotide content using HPLC.
    Adair CG; Elder GE; Lappin TR; Bridges JM; Nelson MG
    Clin Chim Acta; 1988 Jan; 171(1):75-83. PubMed ID: 2832101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of blood lead by HPLC assay of erythrocyte pyrimidine 5'-nucleotidase.
    Cook LR; Angle CR; Kubitschek CE; Stohs SJ
    J Anal Toxicol; 1987; 11(1):39-42. PubMed ID: 3029506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.